RANDALL MCCARTHY: Open Payments
NPI 1891875878 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 28 payments from 14 companies in 2025. Trend: 2023 $877 · 2024 $759 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $90 |
| Lilly USA, LLC | 4 | $63 |
| Dexcom, Inc. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $31 |
| Novo Nordisk Inc | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| IBSA Pharma Inc. | 1 | $21 |
Products named: MOUNJARO, ELIQUIS, Dexcom G6 Transmitter, XIFAXAN, TRELEGY ELLIPTA, JARDIANCE, PREVNAR 20, EVENITY.
Industry payments across GA — which companies pay providers there.
